Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Apr 2;224(9):1614–1622. doi: 10.1093/infdis/jiab170

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 3. — Elevated circulating levels of angiogenic factors following anthelmintic treatment. A, Plasma levels of vascular endothelial growth factor (VEGF)–A, VEGF-C, VEGF-D, angiopoietin (Ang) 1, and Ang-2 in individuals with type 2 diabetes mellitus (T2DM) infected with Strongyloides stercoralis (Ss⁺) pretreatment (Pre-T, n = 60) and 6 months following treatment (Post-T, n = 60) were measured. B, Plasma levels of VEGF-R1, -R2, -R3, and Ang-2/Ang-1 ratio in individuals with T2DM and Ss⁺ Pre-T (n = 60) and Post-T (n = 60) were measured. P values were calculated using the Wilcoxon matched pairs test.